Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Refine Results

During April 22-28, 2018, Q2 Solutions is celebrating Medical Laboratory Professionals Week, also known as Lab Week. I want to take this opportunity to acknowledge and thank our global laboratory teams for their important work and ongoing commitment to serving our patients, customers, and each other. When I first joined Q2 Solutions and toured our various sites, I noticed an inspirational sign posted in one of our laboratories. It read, “Every laboratory sample we process impacts a patient’s life. Your handling and subsequent analysis provides the essential information used to diagnose and determine treatment options.” This sign had a profound impact on me that I won’t forget: our people... Read More

Topics

ADME , Analytics , Assay Development , Biomarkers , Central Laboratories , Companion Diagnostics , Data Integration , End-to-End Services , Genomics , Immunoassay Services , Precision Medicine , Research and Development , Translational Medicine , Vaccines

This year, the theme for World Immunization Week is “Protected Together, #VaccinesWork.” This theme brings to heart and mind the significant efforts of those who have developed life-saving vaccinations for millions of people across the globe. It also highlights the potential for a great improvement in rates of those diseases for which vaccines are not yet available. Respiratory Syncytial Virus (RSV) is the largest, most significant respiratory disease in children and the elderly for which a successful vaccine has not yet been developed. According to the Centers for Disease Control and Prevention, an average of 2.1 million outpatient visits and more than 57,000 hospitalizations among... Read More

Topics

Vaccines

Authors: Dr. Ayaskant Pany and Sorika Van Niekerk Read somewhere recently: “What is the biggest constraint for tuberculosis (TB) clinical trials? RESOURCES!” This is so true not only in the theoretical sense, but also in practice. From the microbiologic point of view, the TB organism itself is so challenging. Limited funding, manpower, technology, and outreach resources add to the challenge. The scarcity of accredited myco-bacteriological laboratories that are functionally efficient, technically competent, adherent to regulatory and biological safety requirements1 presents a practical constraint. Ideally such a laboratory needs to be within the same geographical location where the trials... Read More

Topics

Vaccines